{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T16:16:38Z","timestamp":1787242598548,"version":"build-2736575974"},"reference-count":54,"publisher":"American Academy of Pediatrics (AAP)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2002,5,1]]},"abstract":"<jats:p>Objective. Osteonecrosis of the hip has been reported in human immunodeficiency virus (HIV)-infected adults; whether this is related to HIV infection or its treatment is unknown. There has been 1 report of osteonecrosis among HIV-infected children. Specifically, avascular necrosis of the hip consistent with Legg-Calve\u0301-Perthes disease (LCPD) was reported in 3 HIV-infected children with AIDS from Spain in 1992. We evaluated the prevalence and incidence of LCPD, the pediatric equivalent of adult osteonecrosis of the hip, in HIV-infected children participating in a prospective cohort study of long-term outcomes in HIV-infected and HIV-exposed children\u2014Pediatric AIDS Clinical Trials Group (PACTG) protocol 219.<\/jats:p>\n                  <jats:p>Methods. PACTG 219 enrolled 2014 HIV-infected and 849 HIV-exposed, uninfected children between April 1993 and September 2000. Children had periodic examinations with collection of clinical and laboratory data. The database was reviewed for reports of LCPD and other bone disorders. A prevalent case was defined as LCPD diagnosis preceding PACTG 219 enrollment and an incident case had to have occurred between enrollment and September 2000. A case-control study (matching on age, gender, and race\/ethnicity, which are known to be associated with risk of LCPD and HIV infection status) was performed to investigate factors possibly associated with LCPD.<\/jats:p>\n                  <jats:p>Results. Six cases of LCPD (4 prevalent cases reported at study entry; 2 diagnosed during 5837 person-years of follow-up) were observed; LCPD was seen only in children with perinatal HIV infection. LCPD prevalence was 199 per 100 000 compared with an estimated general pediatric population prevalence of 23 per 100 000. Based on age-adjusted general population rates, the expected number of prevalent cases at PACTG 219 study entry would have been 0.44; the age-adjusted LCPD prevalence rate ratio was 9.0 (95% confidence interval [CI]: 8.3\u20139.7) for HIV-infected children compared with the general population. LCPD incidence was 34 per 100 000 person-years (95% CI: 0.42\u2013124) compared with the estimated general population incidence of 6 per 100 000 person-years (95% CI: 5\u20137). Based on age-adjusted general population rates, the expected incidence of LCPD in PACTG 219 would have been 0.42; the age-adjusted relative risk of LCPD in HIV-infected PACTG 219 children was 4.8 (95% CI: 0.56\u201310.4). No cases were observed in uninfected children during 1919 person-years of follow-up on PACTG 219; the age-adjusted expected number of cases was 0.09. Median onset age was 7 years; 67% were of Hispanic or black race\/ethnicity and 33% were female. Four of the 6 LCPD cases had received antiretroviral therapy before diagnosis; treatment was primarily with nucleoside reverse transcriptase inhibitors, and 2 had received protease inhibitors. Three of the LCPD cases had corticosteroid exposure before the diagnosis, but only 1 child had systemic exposure and the remaining 2 had topical exposure exclusively. In the case-control study, antiretroviral and corticosteroid therapy, CD4 cell percentage, birth weight, height for age and gender percentile, and triglyceride levels were not significantly associated with LCPD. However, the case-control study had limited power to evaluate possible associations.<\/jats:p>\n                  <jats:p>Conclusion. Similar to HIV-infected adults, children with perinatal HIV infection have an increased risk for osteonecrosis of the hip, and clinicians should be alert to this diagnosis when HIV-infected children present with limp or hip pain. Whether LCPD is attributable to HIV infection itself, HIV-associated complications that could predispose to hypercoagulopathy, HIV-related therapies, or to the growth abnormalities in HIV-infected children is unknown and deserves additional evaluation.<\/jats:p>","DOI":"10.1542\/peds.109.5.e74","type":"journal-article","created":{"date-parts":[[2004,8,13]],"date-time":"2004-08-13T20:17:55Z","timestamp":1092428275000},"page":"e74-e74","source":"Crossref","is-referenced-by-count":35,"title":["Osteonecrosis of the Hip (Legg-Calve\u0301-Perthes Disease) in Human Immunodeficiency Virus-Infected Children"],"prefix":"10.1542","volume":"109","author":[{"given":"Denise M.","family":"Gaughan","sequence":"first","affiliation":[{"name":"Center for Biostatistics in AIDS Research, Harvard School of Public Health, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynne M.","family":"Mofenson","sequence":"additional","affiliation":[{"name":"National Institute of Child Health and Human Development, National Institutes of Health, Rockville, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael D.","family":"Hughes","sequence":"additional","affiliation":[{"name":"Center for Biostatistics in AIDS Research, Harvard School of Public Health, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"III","given":"George R.","family":"Seage","sequence":"additional","affiliation":[{"name":"Center for Biostatistics in AIDS Research, Harvard School of Public Health, Boston, Massachusetts"},{"name":"Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory L.","family":"Ciupak","sequence":"additional","affiliation":[{"name":"Frontier Science and Technology Research Foundation, Amherst, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James M.","family":"Oleske","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University of Medicine and Dentistry of New Jersey, New Jersey Medical School, Newark, New Jersey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"for the Pediatric AIDS Clinical Trials Group Protocol 219 Team","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"417","published-online":{"date-parts":[[2002,5,1]]},"reference":[{"key":"2021121006294000300_R1","doi-asserted-by":"crossref","unstructured":"Goorney BP, Lacey H, Thurairajasingam S, Brown JDK. Avascular necrosis of the hip in a man with HIV infection. Genitourin Med.1990;66:451\u2013452","DOI":"10.1136\/sti.66.6.451"},{"key":"2021121006294000300_R2","unstructured":"Gerster JL, Camus JP, Chave JP, et al. Multiple site avascular necrosis in HIV-infected patients. J Rheumatol.1991;18:300\u2013302"},{"key":"2021121006294000300_R3","doi-asserted-by":"crossref","unstructured":"Chevalier X, Larget-Piet B, Hernigou P, Gheradi R. Avascular necrosis of the femoral head in HIV-infected patients. J Bone Joint Surg Br.1993;75:160","DOI":"10.1302\/0301-620X.75B1.8421018"},{"key":"2021121006294000300_R4","unstructured":"Belmonte MA, Garcia-Portales R, Domenech I, et al. Avascular necrosis of bone in human immunodeficiency virus infection and antiphospholipid antibodies. J Rheumatol.1993;20:1425\u20131428"},{"key":"2021121006294000300_R5","unstructured":"Tigges S, Meli RJ. Osteonecrosis associated with HIV infection. Can Assoc Radiol J.1995;46:280\u2013284"},{"key":"2021121006294000300_R6","unstructured":"Stovall D, Young TR. Avascular necrosis of the medial femoral condyle in HIV-infected patients. Am J Orthop.1995;24:71\u201373"},{"key":"2021121006294000300_R7","unstructured":"Molina JF, Citera G, Rosler. Coexistence of human immunodeficiency virus infection and systemic lupus erythematous. J Rheumatol.1995;22:347\u2013350"},{"key":"2021121006294000300_R8","unstructured":"Rademaker JR, Dobro JS, Solomon G. Osteonecrosis and human immunodeficiency virus infection. J Rheumatol.1997;24:601\u2013604"},{"key":"2021121006294000300_R9","doi-asserted-by":"crossref","unstructured":"Calza L, Manfredi R, Mastroianni A, Chiodo F. Osteonecrosis and highly active antiretroviral therapy during HIV infection: report of a series and literature review. AIDS Patient Care STDs.2001;15:385\u2013389","DOI":"10.1089\/108729101750301933"},{"key":"2021121006294000300_R10","unstructured":"Masur H. Perspectives: metabolic complications in HIV disease: lactemia and bone disease. Top Med.2001;9:8\u201311"},{"key":"2021121006294000300_R11","doi-asserted-by":"crossref","unstructured":"Brown P, Crane L. Avascular necrosis of bone in patients with human immunodeficiency virus infection: report of 6 cases and review of the literature. Clin Infect Dis.2001;32:1221\u20131226","DOI":"10.1086\/319745"},{"key":"2021121006294000300_R12","doi-asserted-by":"crossref","unstructured":"Meyer D, Behrens G, Schmidt RE, et al. Osteonecrosis of the femoral head in patients receiving HIV protease inhibitors. AIDS.1999;13:1147\u20131148","DOI":"10.1097\/00002030-199906180-00025"},{"key":"2021121006294000300_R13","doi-asserted-by":"crossref","unstructured":"Monier P, McKown K, Bronze MS. Osteonecrosis complicating highly active antiretroviral therapy in patients infected with human immunodeficiency virus. Clin Infect Dis.2000;31:1488\u20131492","DOI":"10.1086\/317503"},{"key":"2021121006294000300_R14","doi-asserted-by":"crossref","unstructured":"Keruly JC, Chaisson RE, Moore RD. Increasing incidence of avascular necrosis of the hip in HIV-infected patients. J Acquir Immune Defic Syndr.2001;28:101\u2013102","DOI":"10.1097\/00042560-200109010-00017"},{"key":"2021121006294000300_R15","doi-asserted-by":"crossref","unstructured":"Glesby MJ, Hoover DR, Vaamonde CM. Osteonecrosis in patients infected with human immunodeficiency virus: a case-control study. J Infect Dis.2001;184:519\u2013523","DOI":"10.1086\/322779"},{"key":"2021121006294000300_R16","doi-asserted-by":"crossref","unstructured":"Aukrust P, Huang CJ, Ueland T, et al. Decreased bone formative and enhanced resortptive markers in human immunodeficiency virus infection: indication of normalization of the bone-remodeling process during highly active antiretroviral therapy. J Clin Endocrinol Metab.1999;84:145\u2013150","DOI":"10.1210\/jc.84.1.145"},{"key":"2021121006294000300_R17","doi-asserted-by":"crossref","unstructured":"Tebas P, Powderly WG, Claxton S, et al. Accelerated bone mineral loss in HIV-infected patients receiving potent antiretroviral therapy. AIDS.2000;14:F63\u2013F67","DOI":"10.1097\/00002030-200003100-00005"},{"key":"2021121006294000300_R18","doi-asserted-by":"crossref","unstructured":"Carr A, Miller J, Eisman JA, Cooper DA. Osteopenia in HIV-infected men: association with asymptomatic lactic acidemia and lower weight pre-antiretroviral therapy. AIDS.2001;15:703\u2013709","DOI":"10.1097\/00002030-200104130-00005"},{"key":"2021121006294000300_R19","doi-asserted-by":"crossref","unstructured":"Koller E. Mann M. Malozowski S. Bacsanyi J. Gibert C. Aseptic necrosis in HIV seropositive patients: a possible etiologic role for megestrol acetate. AIDS Patient Care STDS.2000;14:405\u2013410","DOI":"10.1089\/108729100416614"},{"key":"2021121006294000300_R20","doi-asserted-by":"crossref","unstructured":"Blacksin MF, Kloser PC, Simon J. Avascular necrosis of bone in human immunodeficiency virus infected patients. Clin Imaging.2000;23:314\u2013318","DOI":"10.1016\/S0899-7071(99)00151-5"},{"key":"2021121006294000300_R21","doi-asserted-by":"crossref","unstructured":"Scribner AN, Troia-Cancio PV, Cox BA, et al. Osteonecrosis in HIV: a case-control study. J Acquir Immune Defic Syndr.2000;25:19\u201325","DOI":"10.1097\/00126334-200009010-00003"},{"key":"2021121006294000300_R22","doi-asserted-by":"crossref","unstructured":"Fairfield WP, Finkelstein JS, Klibanski A, Grinspoon SK. Osteopenia in eugonadal men with acquired immune deficiency syndrome wasting syndrome. J Clin Endocrinol Metab.2001;86:2020\u20132026","DOI":"10.1210\/jc.86.5.2020"},{"key":"2021121006294000300_R23","unstructured":"Martin-Crespo R, Escorihuela A, Soleto J, et al. Hip disease in AIDS children. VIII International Conference on AIDS; July 19\u201324,1992; Amsterdam, the Netherlands. Abstract PuB7340"},{"key":"2021121006294000300_R24","doi-asserted-by":"crossref","unstructured":"Molloy MK, MacMahon B. Incidence of Legg-Perthes disease (osteocohondritis deformans). N Engl J Med.1966;275:988\u2013990","DOI":"10.1056\/NEJM196611032751804"},{"key":"2021121006294000300_R25","doi-asserted-by":"crossref","unstructured":"Purry NA. The incidence of Perthes disease in three population groups in the Eastern Cape region of South Africa. J Bone Joint Surg.1982;64:286\u2013288","DOI":"10.1302\/0301-620X.64B3.7096393"},{"key":"2021121006294000300_R26","unstructured":"Ebong WW. Legg-Calve\u0301 Perthes disease in Nigerians. Int Surg.1977;62:217\u2013218"},{"key":"2021121006294000300_R27","doi-asserted-by":"crossref","unstructured":"Barker DJ, Hall AJ. The epidemiology of Perthes disease. Clin Orthop.1986;209:89\u201394","DOI":"10.1097\/00003086-198608000-00012"},{"key":"2021121006294000300_R28","doi-asserted-by":"crossref","unstructured":"Roy DR. Current concepts in Legg-Calve-Perthes disease. Pediatr Ann.1999;28:748\u2013752","DOI":"10.3928\/0090-4481-19991201-09"},{"key":"2021121006294000300_R29","unstructured":"CDC Growth Charts. United States. Available at: http:\/\/www.cdc.gov\/growthcharts. Accessed August 1,2001"},{"key":"2021121006294000300_R30","doi-asserted-by":"crossref","unstructured":"Wynne-Davies R. Some etiological factors in Perthes\u2019 disease. Clin Orthop.1980;150:12\u201315","DOI":"10.1097\/00003086-198007000-00005"},{"key":"2021121006294000300_R31","doi-asserted-by":"crossref","unstructured":"Margetts BM, Perry CA, Taylor JF, Dangerfield PH. The incidence and distribution of Legg-Calve-Perthes disease in Liverpool, 1982\u201395. Arch Dis Child.2001;84:351\u2013354","DOI":"10.1136\/adc.84.4.351"},{"key":"2021121006294000300_R32","doi-asserted-by":"crossref","unstructured":"Della-Giustina K, Della-Giustina DA. Emergency department evaluation and treatment of pediatric orthopedic injuries. Emerg Med Clin North Am.1999;17:895\u2013922","DOI":"10.1016\/S0733-8627(05)70103-6"},{"key":"2021121006294000300_R33","doi-asserted-by":"crossref","unstructured":"Molloy MK, MacMahon B. Birth weight and Legg-Perthe\u2019s disease. J Bone Joint Surg.1967;49-A:498\u2013506","DOI":"10.2106\/00004623-196749030-00008"},{"key":"2021121006294000300_R34","doi-asserted-by":"crossref","unstructured":"Burwell RG. Perthes disease: growth and etiology. Arch Dis Child.1988;63:1408\u20131412","DOI":"10.1136\/adc.63.11.1408"},{"key":"2021121006294000300_R35","doi-asserted-by":"crossref","unstructured":"Pollock H, Glasberg H, Lee E. Impaired early growth of perinatally infected with human immunodeficiency virus: correlation with viral load. J Pediatr.1997;130:915\u2013922","DOI":"10.1016\/S0022-3476(97)70277-4"},{"key":"2021121006294000300_R36","doi-asserted-by":"crossref","unstructured":"Saavedra JM, Henderson RA, Perman JA, Hutton N, Livingston RA, Yolken RH. Longitudinal assessment of growth in children born to mothers with human immunodeficiency virus infection. Arch Pediatr Adolesc Med.1995;149:497\u2013502","DOI":"10.1001\/archpedi.1995.02170180027004"},{"key":"2021121006294000300_R37","doi-asserted-by":"crossref","unstructured":"Moye J, Rich KC, Kalish LA, et al. Natural history of somatic growth in infants born to women infected by human immunodeficiency virus. J Pediatr.1996;128:58\u201369","DOI":"10.1016\/S0022-3476(96)70428-6"},{"key":"2021121006294000300_R38","doi-asserted-by":"crossref","unstructured":"Ratner Kaufman F, Gertner JM, Sleeper LA, Donfield SM. Growth hormone secretion in HIV-positive versus HIV-negative hemophiliac males with abnormal growth and pubertal development. The Hemophilia Growth and Development Study. J Acquir Immune Defic Syndr.1997;15:137\u2013144","DOI":"10.1097\/00042560-199706010-00007"},{"key":"2021121006294000300_R39","doi-asserted-by":"crossref","unstructured":"O\u2019Brien KO, Razavi M, Henderson RA, Caballero B, Ellis KJ. Bone mineral content in girls perinatally infected with HIV. Am J Clin Nutr.2001;73:821\u2013826","DOI":"10.1093\/ajcn\/73.4.821"},{"key":"2021121006294000300_R40","doi-asserted-by":"crossref","unstructured":"Glueck CJ, Freiberg RA, Fontaine RN, Tracy T, Wang P. Hypofibrinolysis, thrombophilia, osteonecrosis. Clin Orthop.2001;386:19\u201333","DOI":"10.1097\/00003086-200105000-00004"},{"key":"2021121006294000300_R41","doi-asserted-by":"crossref","unstructured":"Glueck CJ, Clueck HI, Greenfield D, et al. Protein C and S deficiency, thrombophilia, and hypofibrinolysis: pathophysiologic causes of Legg-Perthes disease. Pediatr Res.1994;35:383\u2013388","DOI":"10.1203\/00006450-199404000-00001"},{"key":"2021121006294000300_R42","doi-asserted-by":"crossref","unstructured":"Arruda VR, Belangero WD, Ozelo MC, et al. Inherited risk factors for thrombophilia among children with Legg-Calve\u0301-Perthes disease. J Pediatr Orthop.1999;19:84\u201387","DOI":"10.1097\/01241398-199901000-00019"},{"key":"2021121006294000300_R43","doi-asserted-by":"crossref","unstructured":"Gruppo R, Glueck C, Wall E, et al. Legg-Perthes disease in three siblings, two heterozygous and one homozygous for the factor V Leiden mutation. J Pediatr.1998;132:885\u2013888","DOI":"10.1016\/S0022-3476(98)70326-9"},{"key":"2021121006294000300_R44","doi-asserted-by":"crossref","unstructured":"Glueck CJ, Brandt G, Gruppo R, et al. Resistance to activated protein C and Legg-Perthes disease. Clin Orthop.1997;338:139\u2013152","DOI":"10.1097\/00003086-199705000-00021"},{"key":"2021121006294000300_R45","doi-asserted-by":"crossref","unstructured":"Glueck CJ, Crawford A, Roy D, Freiberg R, Clueck H, Stroop D. Association of antithrombotic factor deficiencies and hypofibrinolysis with Legg-Perthes disease. J Bone Joint Surg.1996;78:3\u201313","DOI":"10.2106\/00004623-199601000-00002"},{"key":"2021121006294000300_R46","doi-asserted-by":"crossref","unstructured":"Eldridge J, Dilley A, Austin H, et al. The role of protein C, protein S, and resistance to activated protein C in Legg-Perthes disease. Pediatrics.2001;107:1329\u20131334","DOI":"10.1542\/peds.107.6.1329"},{"key":"2021121006294000300_R47","doi-asserted-by":"crossref","unstructured":"Blangy H, Loeuille D, Chary-Valckenaere, Christian B, May T, Gillet P. Osteonecrosis of the femoral head in HIV-1-infected patients: four additional cases. AIDS.2000;14:2214\u20132215","DOI":"10.1097\/00002030-200009290-00025"},{"key":"2021121006294000300_R48","doi-asserted-by":"crossref","unstructured":"Sugerman RW, Church JA, Goldsmith JC, Ens GE. Acquired protein S deficiency in children infected with human immunodeficiency virus. Pediatr Infect Dis J.1996;15:106\u2013111","DOI":"10.1097\/00006454-199602000-00003"},{"key":"2021121006294000300_R49","doi-asserted-by":"crossref","unstructured":"Bissuel F, Verruyer M, Causse X, Dechavanne M, Trepo C. Acquired protein S deficiency: correlation with advanced disease in HIV-1-infected patients. J Acquir Immune Defic Syndr.1992;5:484\u2013489","DOI":"10.1097\/00126334-199205000-00009"},{"key":"2021121006294000300_R50","doi-asserted-by":"crossref","unstructured":"Stahl CP, Wideman CS, Spira TJ, et al. Protein S deficiency in men with long-term human immunodeficiency virus infection. Blood.1993;81:1801\u20131807","DOI":"10.1182\/blood.V81.7.1801.1801"},{"key":"2021121006294000300_R51","doi-asserted-by":"crossref","unstructured":"Monier P, Bronze MS. Osteonecrosis in human immunodeficiency virus-infected patients may not be related to immune reconstitution [reply]. Clin Infect Dis.2001;33:269\u2013270","DOI":"10.1086\/321827"},{"key":"2021121006294000300_R52","doi-asserted-by":"crossref","unstructured":"Skiest DJ. Osteonecrosis in human immunodeficiency virus-infected patients may not be related to immune reconstitution. Clin Infect Dis.2001;33:268\u2013269","DOI":"10.1086\/321826"},{"key":"2021121006294000300_R53","doi-asserted-by":"crossref","unstructured":"Kubo T, Kojima A, Yamazoe S, Ueshima K, Yamamoto T, Hirasawa Y. Osteonecrosis of the femoral head that developed after long-term topical steroid application. J Orthop Sci.2001;6:92\u201394","DOI":"10.1007\/s007760170031"},{"key":"2021121006294000300_R54","unstructured":"Tang SC, Chan KC, Chow SP. Osteonecrosis of femoral head after topical steroid therapy. J R Coll Surg Edinb.1986;31:321\u2013323"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/109\/5\/e74\/1114962\/pe0502000e74.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/109\/5\/e74\/1114962\/pe0502000e74.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,10]],"date-time":"2021-12-10T09:57:49Z","timestamp":1639130269000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/109\/5\/e74\/64295\/Osteonecrosis-of-the-Hip-Legg-Calve-Perthes"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,5,1]]},"references-count":54,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2002,5,1]]},"published-print":{"date-parts":[[2002,5,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.109.5.e74","relation":{},"ISSN":["0031-4005","1098-4275"],"issn-type":[{"value":"0031-4005","type":"print"},{"value":"1098-4275","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,5,1]]}}}